Pradžia › Priekamirių fibriliacija › Oklahoma
Priekamirių fibriliacija klinikiniai tyrimai Oklahoma
8 tyrimai dėl Priekamirių fibriliacija ieško dalyvių vietose Oklahoma.
Miestai Oklahoma
Oficialus tyrimo tekstas (anglų kalba)
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- University of Oklahoma Health Sciences Center, Oklahoma City
Renkami dalyviai3 fazė
Amžius nuo 22 iki 85 · Visoms lytims · Atnaujinta 2026-09-30 · NCT05836987A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Oklahoma Heart Hospital, Oklahoma City
Renkami dalyviai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07527299Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Oklahoma Heart Hospital, Oklahoma City
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT04088071The Fourth Left Atrial Appendage Occlusion Study
- Saint Francis Hospital, Tulsa
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT05963698Detection of Atrial Fibrillation Using PPG From Smartphone Cameras
- CardioVascular Health Clinic, Oklahoma City
Renkami dalyviaiStebimasis tyrimas
22 Minutes · Visoms lytims · Atnaujinta 2026-08-21 · NCT07779213Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 9917, Oklahoma City
Renkami dalyviai3 fazė
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT05712200Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- OU Medical Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
- Ascension St. John Medical Center, Tulsa
- ir dar 1
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-08 · NCT03907046Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
- University of Oklahoma Health Sciences Center, Oklahoma City
Renkami dalyviai3 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-04-01 · NCT05174052Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.